ClinicalTrials.Veeva

Menu

The Efficacy of Surgical Site Treatment With Ropivacaine in Laparoscopic Surgery

W

Western Galilee Hospital-Nahariya

Status

Unknown

Conditions

Pain

Treatments

Other: laparoscopic repair of inguinal hernia
Other: laparoscopic bariatric surgery
Drug: Topical use

Study type

Interventional

Funder types

Other

Identifiers

NCT02826876
0196-15-NHR

Details and patient eligibility

About

Using local analgesia in laparoscopic surgery in order to reduce pain and to reduce the use of narcotic drugs.

Full description

At the end of laparoscopic surgery the investigators will spray ropivacaine in the surgical site; and later the investigators will monitor pain intensity and use of analgesic drugs

Enrollment

100 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Laparoscopic bariatric surgery
  • Laparoscopic inguinal hernia surgery

Exclusion criteria

  • Cardiac arrythmias
  • Active ischemic heart disease
  • pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

100 participants in 2 patient groups, including a placebo group

Ropivacaine
Placebo Comparator group
Description:
Topical use of Ropivacaine
Treatment:
Other: laparoscopic bariatric surgery
Drug: Topical use
Other: laparoscopic repair of inguinal hernia
Placebo
Placebo Comparator group
Description:
Topical use of placebo
Treatment:
Other: laparoscopic bariatric surgery
Drug: Topical use
Other: laparoscopic repair of inguinal hernia

Trial contacts and locations

1

Loading...

Central trial contact

Moaad H Farraj, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems